IVI announced the licensure of Shanchol, an oral cholera vaccine, in India in 2009, noting that “efforts to accelerate the global use of new generation cholera vaccines gained significant momentum with the licensure. IVI said its scientists developed this vaccine, with funding from the Bill & Melinda Gates Foundation, “by significantly modifying a vaccine used and produced only in Vietnam so that it meets international Good Manufacturing Practice (GMP) standards and WHO production guidelines.”

http://www.ivi.org/popup/files/ocv_article.pdf